Weak neural connections previously dismissed as noise can predict behavior with accuracy comparable to strong signals, suggesting that analyzing this 'hidden iceberg' of brain activity offers critical new insights for understanding psychiatric disorders.

Superagers exhibit superior episodic memory through enhanced hippocampal responses to expectation violations and preserved midbrain habituation, indicating that adaptive processing of prediction errors distinguishes exceptional from typical cognitive aging.

This protocol outlines a multimodal MRI study designed to characterize the neural mechanisms of interoceptive dysfunction in schizophrenia, aiming to link deficits in bodily self-awareness to specific circuit abnormalities for future therapeutic development.

High gut microbial diversity correlates with enhanced stress response flexibility, suggesting bacterial metabolites like butyrate and propionate as potential therapeutic targets for stress-related psychiatric disorders.

A high-resolution genomic analysis identifies over 3,000 sex-biased genes in adult brains, providing a molecular basis for observed sex disparities in disorders such as ADHD and Alzheimer's disease.

This article details a $108M investment for a vaccine manufacturing facility in South Africa, which is unrelated to clinical psychiatric practice or pharmacotherapy.

Revolution Medicines' valuation surge following positive Phase 3 pancreatic cancer data highlights the critical impact of oncology trial outcomes on biotech M&A activity and therapeutic pipeline viability.

Yvonne McGrath has been appointed as chief scientific officer at Enodia Therapeutics, bringing prior experience from iTeos Therapeutics.

Eli Lilly's weight loss drug Foundayo demonstrated cardiovascular risk reduction and no liver safety signals in a Phase 3 trial, addressing FDA-mandated safety concerns, while emerging research suggests GIP/glucagon receptor activation may offer comparable weight loss to GLP-1 agonists with fewer gastrointestinal side effects.

Kailera Therapeutics achieved a record-breaking $625M IPO, signaling strong investor confidence in its biotech pipeline and the current capital market environment for novel therapeutics.

The provided text does not contain clinical information, as it is a promotional teaser for an external article regarding ICE detention deaths rather than a substantive medical report.

This article details significant compensation increases for pharmaceutical CEOs in 2025, highlighting a trend toward executive pay exceeding $30 million, which has no direct clinical or therapeutic implications for psychiatric practice.

[OUT OF SCOPE] This article discusses healthcare cybersecurity and ransomware impacts on hospital operations, not psychiatric pharmacology or treatment.

Clinicians must actively counter the normalization of vaccine skepticism by correcting distorted media narratives that falsely portray doubt as the majority view, which can inadvertently erode patient trust in immunization.

A recent federal ruling reinforces that arbitration decisions under the No Surprises Act are highly resistant to judicial challenge, signaling significant legal stability for independent dispute resolution outcomes in psychiatric and medical billing disputes.

The Artemis II mission provides critical insights into the psychological resilience, crew dynamics, and stress management strategies required for long-duration deep-space psychiatric care.

Flexible polyimide-based neural implants significantly reduce glial scarring and improve long-term biocompatibility compared to rigid probes, enhancing their potential for restoring functions like sight.

OpenAI's launch of GPT-Rosalind marks a significant expansion of generative AI into biopharma, offering clinicians and researchers new tools for specialized scientific workflows.

Healthcare AI is rapidly evolving beyond administrative tasks and clinical scribes into complex diagnostic and therapeutic tools that require clinicians to critically evaluate their role in the decision-making loop.

Medical AI must be designed to interpret the nuanced, non-compressible narrative of patient history (HPI) rather than merely transcribing data, as clinical significance is fundamentally conditioned by the lived story preceding diagnostic testing.

Deep brain stimulation targeting hippocampal white matter at 50 Hz enhances memory while gray matter stimulation at 5 Hz impairs it, driven by distinct region-specific theta modulation and global fidelity mechanisms that enable state-dependent therapeutic precision.

High schizotypy exhibits reduced frontal-to-temporal top-down connectivity and compensatory cortical disinhibition, mirroring mechanisms in schizophrenia and offering a biomarker for psychosis risk.

Psilocybin modulates cortical inhibition by selectively suppressing somatostatin-expressing interneurons via 5-HT1A receptors while enhancing parvalbumin-expressing interneuron activity, revealing a critical cell-type-specific mechanism underlying its therapeutic effects.

Ceruloplasmin deficiency induces a specific fusiform gyrus lipid-myelin pathology that underlies a distinct visual subtype of autism, suggesting a novel metabolic target for diagnosis and treatment.

The MLKL protein drives blood stem cell aging via mitochondrial damage, suggesting that inhibiting this pathway could preserve immune system function in older adults.

MSF says Gilead's lenacapavir supply 'not nearly enough'; PolyPeptide’s strategic review

The provided text contains only a title and lacks clinical data, making it impossible to extract a specific psychiatric takeaway or determine its relevance.

This document serves as a formal correction notice for the article 'Psychedelic therapeutics in psychiatric conditions' published in Neuropsychopharmacology.

This correction article clarifies author affiliations and funding sources for a study on Yazidi refugee mental health, ensuring accurate attribution for future clinical research on culturally sensitive care barriers.

This article is a formal administrative correction to a previous Lancet Psychiatry series on COVID-19 mental health care to add missing professorial affiliations for four contributing authors.

Clinicians should leverage stress-induced adrenaline release, strategic sleep and exercise protocols, and specific cognitive tools to enhance memory consolidation and learning efficiency in patients.

The article emphasizes the integration of clinical expertise, empathy, and interpersonal skills alongside evidence-based medicine to define high-quality psychiatric practice.

Clinicians are encouraged to integrate personal values with scientific rigor to address the full spectrum of psychiatric care, including neurobiological, clinical, and societal dimensions.

The Psychonauts project demonstrates that collaborative art therapy in forensic settings can empower patients to reclaim agency through collective authorship, yielding significant therapeutic value and global recognition.